# US 2013/0158243 A1 · Process for conjugation of nhs esters with oligonucleotides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0158243 A1
- Document ID: US20130158243A1
- Status: Published application
- Kind: A1
- Application number: 13/719,901
- Filed: 2012-12-19
- Published: 2013-06-20
- Earliest claimed: 2011-12-19
- Assignees: Sigma-Aldrich Co.
- Inventors: Robert William Ball
- Web page: https://patentgrep.com/patent/US20130158243A1

## CPC

- C07H 1/00: Processes for the preparation of sugar derivatives
- C07H 21/04: with deoxyribosyl as saccharide radical
- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C12N 2310/351: Conjugate
- C12N 2330/30: chemically synthesised
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention provides processes for the conjugation of NHS esters to amino-modified oligonucleotides. The processes provide the amino-modified oligonucleotide on a solid support such that conjugation can be carried out under conditions that can accommodate a wide variety of NHS esters and oligonucleotides.

## Claims

### Claim 1

A process for conjugating a N-hydroxysuccinimide ester with an amino-modified oligonucleotide, the process comprising contacting the N-hydroxysuccinimide ester with the amino-modified oligonucleotide, wherein the amino-modified oligonucleotide is non-covalently bound to an ion exchange support.

### Claim 2 (depends on 1)

The process of claim 1, wherein the N-hydroxysuccinimide ester is of the Formula (I):
wherein R1 is chosen from hydrocarbyl and substituted hydrocarbyl.

### Claim 3 (depends on 1)

The process of claim 1, wherein R1 comprises a fluorescent moiety, a dye, or a label.

### Claim 4 (depends on 1)

The process of claim 1, wherein the amino-modified oligonucleotide comprises from about 5 to about 500 bases.

### Claim 5 (depends on 1)

The process of claim 1, wherein the amino-modified oligonucleotide has a mass-average molecular weight of about 500 to about 100,000 Da.

### Claim 6 (depends on 1)

The process of claim 1, wherein the amino-modified oligonucleotide has a mass-average molecular weight of about 1,500 to about 40,000 Da.

### Claim 7 (depends on 1)

The process of claim 1, wherein the amino group comprising the amino-modified oligonucleotide is free during conjugation.

### Claim 8 (depends on 1)

The process of claim 1, wherein conjugation is conducted in a non-aqueous environment.

### Claim 9 (depends on 1)

The process of claim 1, wherein the ion exchange support comprises a strong base exchanger.

### Claim 10 (depends on 1)

The process of claim 1, wherein the ion exchange support comprises a quaternary or tertiary amine.

### Claim 11

A process for conjugating an N-hydroxysuccinimide ester with an amino-modified oligonucleotide, the process comprising contacting the N-hydroxysuccinimide ester with the amino-modified oligonucleotide bound to a solid support, wherein the process is conducted in a non-aqueous environment.

### Claim 12 (depends on 11)

The process of claim 11, wherein the N-hydroxysuccinimide ester is of the Formula (I):
wherein R1 is chosen from hydrocarbyl and substituted hydrocarbyl.

### Claim 13 (depends on 11)

The process of claim 11, wherein R1 comprises a fluorescent moiety, a dye, or a label.

### Claim 14 (depends on 11)

The process of claim 11, wherein the amino group comprising the amino-modified oligonucleotide is free during conjugation.

### Claim 15

A process for producing an oligonucleotide comprising an R1 moiety, the process comprising:
(a) contacting an amino-modified oligonucleotide with an ion exchange support such that the amino-modified oligonucleotide binds to the support;
(b) contacting the supported amino-modified oligonucleotide with an N-hydroxysuccinimide ester comprising R1; and
(c) eluting the oligonucleotide comprising R1,
wherein R1 is chosen from hydrocarbyl and substituted hydrocarbyl.

### Claim 16 (depends on 15)

The process of claim 15, wherein R1 comprises a fluorescent moiety, a dye, or a label.

### Claim 17 (depends on 15)

The process of claim 15, wherein the process is conducted in an organic solvent.

### Claim 18 (depends on 15)

The process of claim 15, wherein step (b) is conducted in a non-aqueous environment.

### Claim 19 (depends on 15)

The process of claim 15, wherein the amino-modified oligonucleotide has a mass-average molecular weight of about 500 to about 100,000 Da.

### Claim 20 (depends on 15)

The process of claim 15, wherein the amino-modified oligonucleotide has a mass-average molecular weight of about 1,500 to about 40,000 Da.
